Wenxue Ma (W Ma)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Cancers

Cancer science

Current oncology (Toronto, Ont.)

Science advances

University of California, San Diego

Zhejiang University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California, San Diego Jul 01 2020

United States

Team Leader/Full Project Scientist :: Dept. of Medicine

University of California San Diego Jul 01 2013 - Jun 30 2020

United States

Team Leader/Associate Project Scientist :: Moores Cancer Center

Cynvenio Biosystems Inc Dec 01 2014 - Jun 30 2015

United States

Senior Scientist :: Research & Development

Huzhou University Dec 17 2012 - Aug 31 2014

China

Dean/Professor :: School of Medicine

University of California San Diego Jul 01 2007 - Jul 01 2013

United States

Team Leader/Assistant Project Scientist :: Moores Cancer Center

Education History

Zhejiang University School of Medicine Sep 01 1999 - Jul 01 2002

China

PHD :: Immuno-Oncology

Zhejiang University School of Medicine Sep 01 1994 - Jul 11 1997

China

MSC :: Clinical Oncology

Publications

Ying Bao, Dejing Zhang, Huihui Guo, Wenxue Ma
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Cancer science 115 (4) (2024)
Ying Bao, Dejing Zhang, Huihui Guo, Wenxue Ma
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Cancer science 115 (4) (2024)
Ying Bao, Dejing Zhang, Huihui Guo, Wenxue Ma
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Cancer science 115 (4) (2024)
Ying Bao, Dejing Zhang, Huihui Guo, Wenxue Ma
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Cancer science (2024)
Ying Bao, Dejing Zhang, Huihui Guo, Wenxue Ma
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Cancer science 115 (4) (2024)
Liqin Yao, Qingqing Wang, Wenxue Ma
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance. Cancers 15 (24) (2023)
Liqin Yao, Qingqing Wang, Wenxue Ma
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance. Cancers 15 (24) (2023)
Qiuqiang Chen, Changquan Ling, Wenxue Ma
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. Cancers 14 (23) (2022)
Qiuqiang Chen, Changquan Ling, Wenxue Ma
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. Cancers 14 (23) (2022)
Qiuqiang Chen, Changquan Ling, Wenxue Ma
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. Cancers 14 (23) (2022)
Liqin Yao, Gang Jia, Changquan Ling, Wenxue Ma
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies? Current oncology (Toronto, Ont.) 29 (7) (2022)
Qiuqiang Chen, Changquan Ling, Wenxue Ma
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. Cancers 14 (23) (2022)
Sung Chang Lee, Jennifer S Y Ma, Min Soo Kim, Eduardo Laborda, Sei-Hyun Choi, Eric N Hampton, Hwayoung Yun, Vanessa Nunez, Michelle T Muldong, Christina N Wu, Wenxue Ma, Anna A Kulidjian, Christopher J Kane, Vadim Klyushnichenko, Ashley K Woods, Sean B Joseph, Mike Petrassi, John Wisler, Jing Li, Christina A M Jamieson, Peter G Schultz, Chan Hyuk Kim, Travis S Young
A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Science advances 7 (33) (2021)
Qiuqiang Chen, Ying Bao, Danielle Burner, Sharmeela Kaushal, Yu Zhang, Theresa Mendoza, Michael Bouvet, Cengiz Ozkan, Boris Minev, Wenxue Ma
Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses. Drug delivery and translational research 9 (6) (2020)
Q Chen, L Yao, D Burner, B Minev, L Lu, M Wang, Wenxue Ma
Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (4) (2018)
Hua Li, Shengwen Shao, Jianshu Cai, Danielle Burner, Lingeng Lu, Qiuqiang Chen, Boris Minev, Wenxue Ma
Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses. Immunology 152 (3) (2017)

Wenxue Ma.css-eqlu8i{font-size:small;padding-left:4px;} (W Ma)

Publication Activity (10 Years)

Top Topics

Top Venues

Wenxue Ma (W Ma)